By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the important features of self-archiving policy of Bentham Science journals:
Authors can deposit the first draft of a submitted article on their personal websites, their institution’s repositories or any non-commercial repository for personal use, internal institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal websites, their institution’s repository or any non-commercial repository such as PMC, arXiv after 12 MONTHS of publication on the journal website. In addition, an acknowledgement must be given to the original source of publication and a link should be inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors are allowed the archiving of published version of manuscripts in an institutional repository after the mandatory embargo period. Authors should first contact the Editorial Office of the journal for information about depositing a copy of the manuscript to a repository. Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number of the article in the following sentence: “The published manuscript is available at EurekaSelect via http://www.eurekaselect.com/openurl/content.php?genre=article&doi=[insert DOI].”
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS category. Authors are allowed deposition of such articles on institutional, non-commercial repositories and personal websites immediately after publication on the journal website.
LONG-TERM ARCHIVING OF BENTHAM SCIENCE CONTENT
To ensure permanent access to our publications, Bentham Science has an agreement with Portico to have a long-term preservation of the content published in its journals.
E.B. Souto University of Coimbra Coimbra (Portugal)
Eliana B. Souto is Assistant Professor with Habilitation degree in Pharmaceutical Technology at the Faculty of Pharmacy of University of Coimbra (UC, Portugal). Dr. Souto graduated in pharmaceutical sciences in 2000 from the same university. In 2002 she obtained a post-graduated master's degree in Pharmaceutical Technology from the Faculty of Pharmacy, University of Porto, Portugal. In 2005, she was awarded with the doctoral degree in Pharmaceutical Technology, Biopharmaceutics and Nanotechnology from the Institute of Pharmacy, Free University of Berlin (Germany) and in 2012 received the Habilitation Degree from Fernando Pessoa University, in Porto. Her current research topics include the design, development, and characterization of new drug delivery systems based on innovative nanomaterials. The main areas of professional experience include the design and construction of (lipid, polymeric, protein-based and polysaccharide-based) nanomaterials for drug therapy with particular emphasis for the treatment of endocrine diseases. Since 2004, Dr. Souto has published more than 150 papers in scientific journals with international referee, edited 4 books and contributed with more than 40 book chapters published by Elsevier, CRC Press and Taylor & Francis, Pan Stanford Publishing, Nova Science Publishers, Humana Press, Studium Press LLC, i-Smithers, American Scientific Publishers, Allured Publishing, John Wiley & Sons, Springer Verlag. The scientific production also includes more than 60 Conference Proceedings and 120 Abstracts presented in international conferences.